We first analyzed the presence of JAK2-V617F mutation when the disease was transformed into AML in April 2010 by the allele-specific PCR method [20] and detected the 203-bp band specific for the mutation (data not shown). This evidence concerns the gene JAK2 and acute myeloid leukemia.